General Information of Drug (ID: DMNAHVB)

Drug Name
6-(4-Chloro-benzenesulfonyl)-2H-pyridazin-3-one
Synonyms
SCHEMBL6205548; CHEMBL425745; BDBM16599; MolPort-008-421-579; ZINC11536219; AKOS004915123; AKOS001782171; MCULE-3139216379; CCG-127350; 454181-53-4; Phenyl-Substituted Sulfonylpyridazinone, 8e; 6-[(4-chlorophenyl)sulfonyl]-3-pyridazinol; 6-[(4-chlorophenyl)sulfonyl]-3(2H)-pyridazinone; 3(2H)-Pyridazinone, 6-[(4-chlorophenyl)sulfonyl]-
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 270.69
Logarithm of the Partition Coefficient (xlogp) 1.1
Rotatable Bond Count (rotbonds) 2
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 4
Chemical Identifiers
Formula
C10H7ClN2O3S
IUPAC Name
3-(4-chlorophenyl)sulfonyl-1H-pyridazin-6-one
Canonical SMILES
C1=CC(=CC=C1S(=O)(=O)C2=NNC(=O)C=C2)Cl
InChI
InChI=1S/C10H7ClN2O3S/c11-7-1-3-8(4-2-7)17(15,16)10-6-5-9(14)12-13-10/h1-6H,(H,12,14)
InChIKey
MLRLSUWJTAHEKD-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
9878572
TTD ID
D02AAH

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Aldose reductase (AKR1B1) TTFBNVI ALDR_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Aldose reductase (AKR1B1) DTT AKR1B1 1.08E-20 0.94 1.58
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 A novel series of non-carboxylic acid, non-hydantoin inhibitors of aldose reductase with potent oral activity in diabetic rat models: 6-(5-chloro-3... J Med Chem. 2005 Oct 6;48(20):6326-39.